As of 2025-11-01, the Relative Valuation of Citius Pharmaceuticals Inc (CTXR) is (41.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.58 USD, the upside of Citius Pharmaceuticals Inc based on Relative Valuation is -2755.5%.
The range of the Relative Valuation is (40.90) - (43.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 18.3x | 17.2x |
| Forward P/E multiples | 17.3x - 20.7x | 18.3x |
| Fair Price | (40.90) - (43.32) | (41.96) |
| Upside | -2688.9% - -2841.7% | -2755.5% |
| Date | P/E |
| 2025-10-30 | -0.66 |
| 2025-10-29 | -0.64 |
| 2025-10-28 | -0.65 |
| 2025-10-27 | -0.68 |
| 2025-10-24 | -0.77 |
| 2025-10-23 | -0.73 |
| 2025-10-22 | -0.66 |
| 2025-10-21 | -0.71 |
| 2025-10-20 | -0.76 |
| 2025-10-17 | -0.61 |
| 2025-10-16 | -0.63 |
| 2025-10-15 | -0.59 |
| 2025-10-14 | -0.55 |
| 2025-10-13 | -0.55 |
| 2025-10-10 | -0.52 |
| 2025-10-09 | -0.54 |
| 2025-10-08 | -0.54 |
| 2025-10-07 | -0.59 |
| 2025-10-06 | -0.56 |
| 2025-10-03 | -0.58 |
| 2025-10-02 | -0.56 |
| 2025-10-01 | -0.58 |
| 2025-09-30 | -0.52 |
| 2025-09-29 | -0.50 |
| 2025-09-26 | -0.49 |
| 2025-09-25 | -0.49 |
| 2025-09-24 | -0.50 |
| 2025-09-23 | -0.49 |
| 2025-09-22 | -0.49 |
| 2025-09-19 | -0.50 |
| 2025-09-18 | -0.49 |
| 2025-09-17 | -0.50 |
| 2025-09-16 | -0.49 |
| 2025-09-15 | -0.48 |
| 2025-09-12 | -0.51 |
| 2025-09-11 | -0.51 |
| 2025-09-10 | -0.51 |
| 2025-09-09 | -0.51 |
| 2025-09-08 | -0.52 |
| 2025-09-05 | -0.52 |
| 2025-09-04 | -0.49 |
| 2025-09-03 | -0.52 |
| 2025-09-02 | -0.54 |
| 2025-08-29 | -0.56 |
| 2025-08-28 | -0.59 |
| 2025-08-27 | -0.58 |
| 2025-08-26 | -0.56 |
| 2025-08-25 | -0.53 |
| 2025-08-22 | -0.57 |
| 2025-08-21 | -0.52 |